Now live: Pro — the full 13F research suite for serious investorsSee pricing →
22NW, LP

Q4 2024 · 13F-HR

22NW, LPholdings as filed

Filed 2025-02-14 · accession 0001214659-25-002859

$158.5M
Reported value
16
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
350060109FSTRFOSTER L B CO$35.3M22.3%1,313,121CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$31.1M19.6%1,755,161CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$26.0M16.4%15,467,300CommonSOLE
859241101STRLSTERLING INFRASTRUCTURE INC$16.8M10.6%99,783CommonSOLE
068463108BBSIBARRETT BUSINESS SVCS INC$11.5M7.26%264,904CommonSOLE
230215105CULPCULP INC$9.5M6.02%1,624,715CommonSOLE
71742W103PFXPHENIXFIN CORP$5.9M3.74%117,885CommonSOLE
23331S100DHXDHI GROUP INC$4.6M2.91%2,603,643CommonSOLE
307675108FB1FARMER BROS CO$3.5M2.22%1,955,526CommonSOLE
563571405MTWMANITOWOC CO INC$3.3M2.05%356,115CommonSOLE
516544103LNTHLANTHEUS HLDGS INC$3.1M1.95%34,562CommonSOLE
86183P102SRISTONERIDGE INC$2.1M1.36%342,787CommonSOLE
640268108NKTREURNEKTAR THERAPEUTICS$2.0M1.29%2,191,750CommonSOLE
86272A305SSKNSTRATA SKIN SCIENCES INC$1.6M0.98%536,995CommonSOLE
904677200UFIUNIFI INC$1.5M0.92%233,777CommonSOLE
744375304PMDIPSYCHEMEDICS CORPORATION CMN$618,3160.39%276,034CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.